Voices
Karamvir Yadav: Extended Endocrine Therapy In Premenopausal Node-Positive HR+ Breast Cancer
Karamvir Yadav/X

Karamvir Yadav: Extended Endocrine Therapy In Premenopausal Node-Positive HR+ Breast Cancer

Karamvir Yadav, Medical Oncologist in Jaipur, India, shared posts on X:

“Extended endocrine therapy in premenopausal, node+ HR+ BC 

  • IBCFS: 85% vs 78%
  • DRFS: 91% vs 83%
  • HR 0.49 for distant recurrence

This is not marginal-this is meaningful.”Karamvir Yadav: Extended Endocrine Therapy In Premenopausal Node-Positive HR+ Breast Cancer

Title: Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor–Positive Breast Cancer: A Cohort Study

Authors: Carmine Valenza, Yue Zheng, Monica Milano, Dario Trapani, Elisa Giordano, Lorenzo Guidi, Pier Paolo Maria Berton Giachetti, Laura Boldrini, Grazia Castellano, Jalissa Katrini, Bianca Malagutti, Gabriele Antonarelli, Fabio Conforti, Eleonora Pagan, Vincenzo Bagnardi, Gregory J. Kirkner, Claudia Sangalli, Kate E. Dibble, Marco Colleoni, Meredith M. Regan, Elisabetta Munzone, Giuseppe Curigliano, Ann H. Partridge
Read the Full Article on Journal of Clinical Oncology.

Karamvir Yadav: Extended Endocrine Therapy In Premenopausal Node-Positive HR+ Breast Cancer

Other articles featuring Karamvir Yadav on OncoDaily.

Ann H. Partridge Bianca Malagutti Breast Cancer cancer Carmine Valenza Claudia Sangalli Dario Trapani Eleonora Pagan Elisa Giordano Elisabetta Munzone Fabio Conforti Gabriele Antonarelli Giuseppe Curigliano Grazia Castellano Gregory J. Kirkner Jalissa Katrini Journal of Clinical Oncology Karamvir Yadav Kate E. Dibble Laura Boldrini Lorenzo Guidi Marco Colleoni Meredith M Regan Monica Milano OncoDaily Oncology Pier Paolo Maria Berton Giachetti Vincenzo Bagnardi Yue Zheng